跳至主要内容
临床试验/CTRI/2021/09/036592
CTRI/2021/09/036592尚未招募Phase 3 4

CLINICAL STUDY TO EVALUATE THE EFFICACY OF MATRA BASTI AND KATI BASTI WITH NIRGUNDI TAILA IN THE MANAGEMENT OF KATIGRAHA (LUMBAR SPONDYLOSIS)

Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2021年9月20日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
发起方
入组人数
60
试验地点
1
主要终点
Improvement in subjective and objective

研究概览

简要总结

Spondylosis is very common disease (more than 1 crore cases per year in india)It is a form of lower back pain and is an important clinical, socio-economic and public health problem affecting the world-wide population.Low back pain affects approximately60%-80% of adults and LS is responsible for about 10%of all the back pain conditions. Vatavyadhis  coms under a group of disease which manifest by dhatukshaya or margavaran and those are classified according to hetu, sthan and lakshana. In the classification of dhatukshayajanyavatavyadhis ,many degenerative conditions are considered.In present scenario, the treatment modalities for lumbar spondylosis is conservative treatment with analgesic, physiotherapy,muscle relaxants , narcotics and few require surgery which has its own disadvantages or expensive.

Various internal and external medications and procedures for this disease are available in Ayurveda

The alkaloid nishidine ,present in root of nirgundi .Nirgundi is also reduce swelling and analgesic and anti inflammatory.

Basti is mentioned as the line of treatment of vatavyadhis by Acharyas of Ayurved

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Not Applicable

入排标准

年龄范围
25.00 Year(s) 至 55.00 Year(s)(—)
性别
All

入选标准

  • 1.Patients diagnosed as katigharah.
  • 2.Patient yogya for Basti Karma.

排除标准

  • 1.Patients suffering from Potts spine.
  • 2.Patients suffering from Lumber canal stenosis.
  • 3.Patients suffering from Metastatic disease of spine.
  • 4.Patients suffering from Diabetic neuropathy.
  • 5.Patients suffering from Scoliosis, kyphosis.
  • 6.Patients suffering from Uncontrolled hypertension and history of HIV.

结局指标

主要结局

Improvement in subjective and objective

时间窗: 45day

parameters

时间窗: 45day

次要结局

  • To find out the comparative efficacy of the(treatment in both the groups)

研究者

发起方
Dr Sarvepalli Radhakrishnan Rajasthan Ayurved University Jodhpur
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验